Jeff Yass’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-20,088
| Closed | -$2.74M | – | 12071 |
|
|
2020
Q3 | $2.74M | Sell |
20,088
-68,990
| -77% | -$7.34M | ﹤0.01% | 4033 |
|
|
2020
Q2 | $8.61M | Buy |
89,078
+6,970
| +8% | +$581K | ﹤0.01% | 2316 |
|
|
2020
Q1 | $3.85M | Buy |
+82,108
| New | +$5.26M | ﹤0.01% | 2916 |
|
|
2019
Q4 | – | Sell |
-20,158
| Closed | -$1.22M | – | 11078 |
|
|
2019
Q3 | $1.05M | Sell |
20,158
-17,364
| -46% | -$923K | ﹤0.01% | 5578 |
|
|
2019
Q2 | $1.88M | Buy |
+37,522
| New | +$1.83M | ﹤0.01% | 4290 |
|
|
2019
Q1 | – | Sell |
-14,318
| Closed | -$660K | – | 10291 |
|
|
2018
Q4 | $700K | Buy |
+14,318
| New | +$788K | ﹤0.01% | 5387 |
|
|
2018
Q2 | – | Sell |
-35,281
| Closed | -$1.71M | – | 10771 |
|
|
2018
Q1 | $1.72M | Buy |
35,281
+28,580
| +427% | +$1.49M | ﹤0.01% | 4203 |
|
|
2017
Q4 | $282K | Buy |
+6,701
| New | +$258K | ﹤0.01% | 7695 |
|
|
2017
Q1 | – | Sell |
-19,237
| Closed | -$249K | – | 10418 |
|
|
2016
Q4 | $249K | Buy |
+19,237
| New | +$296K | ﹤0.01% | 8295 |
|
|
2016
Q1 | – | Sell |
-11,635
| Closed | -$171K | – | 9953 |
|
|
2015
Q4 | $171K | Buy |
+11,635
| New | +$142K | ﹤0.01% | 8545 |
|
Jeff Yass's MYOK Position: Q4 2020 in Review
Jeff Yass sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 20,088 shares — an estimated $2.74M sold.
Jeff Yass first reported a position in MYOK in Q4 2015 and held it in 10 quarters. The position peaked at $8.61M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Jeff Yass reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Jeff Yass sold 20,088 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.74M.
- Jeff Yass first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 10 quarters.
- Jeff Yass's MyoKardia, Inc. Common Stock position peaked at $8.61M in Q2 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.